PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-14.74%
Negative revenue growth while IXX.DE stands at 19.08%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-30.35%
Negative gross profit growth while IXX.DE is at 26.44%. Joel Greenblatt would examine cost competitiveness or demand decline.
-41.07%
Negative EBIT growth while IXX.DE is at 47.80%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-45.04%
Negative operating income growth while IXX.DE is at 47.80%. Joel Greenblatt would press for urgent turnaround measures.
-49.05%
Negative net income growth while IXX.DE stands at 90.54%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-48.57%
Negative EPS growth while IXX.DE is at 90.20%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-48.57%
Negative diluted EPS growth while IXX.DE is at 90.20%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-94.77%
Dividend reduction while IXX.DE stands at 125.18%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
244.19%
OCF growth above 1.5x IXX.DE's 30.75%. David Dodd would confirm a clear edge in underlying cash generation.
302.43%
FCF growth above 1.5x IXX.DE's 43.68%. David Dodd would verify if the firm’s strategic investments yield superior returns.
No Data
No Data available this quarter, please select a different quarter.
75.23%
5Y revenue/share CAGR above 1.5x IXX.DE's 47.85%. David Dodd would look for consistent product or market expansions fueling outperformance.
67.06%
3Y revenue/share CAGR above 1.5x IXX.DE's 38.80%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
84.99%
5Y OCF/share CAGR above 1.5x IXX.DE's 40.90%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
112.69%
3Y OCF/share CAGR under 50% of IXX.DE's 872.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
75.88%
Below 50% of IXX.DE's 1611.82%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
590.73%
3Y net income/share CAGR above 1.5x IXX.DE's 107.92%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
77.46%
5Y equity/share CAGR 1.25-1.5x IXX.DE's 60.16%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
56.13%
3Y equity/share CAGR above 1.5x IXX.DE's 37.36%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-88.62%
Negative 5Y dividend/share CAGR while IXX.DE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-33.06%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-36.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-7.43%
Inventory is declining while IXX.DE stands at 3.49%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-8.07%
Negative asset growth while IXX.DE invests at 7.71%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
6.90%
75-90% of IXX.DE's 7.75%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-18.11%
We’re deleveraging while IXX.DE stands at 20.94%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-9.58%
We cut SG&A while IXX.DE invests at 24.41%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.